Atlas FDA

SUPARTZ JOINT FLUID THERAPY

FDA premarket approval P980044/S009 · decided 2009-07-08

Approval details

PMA number
P980044
Supplement
S009
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SUPARTZ JOINT FLUID THERAPY
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2009-02-26
Decision date
2009-07-08
Days to decision
132 days
Decision code
APPR
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
APPROVAL FOR A DISTRIBUTION SITE CHANGE FROM ONE ADDRESS IN MEMPHIS, TENNESSEE TO ANOTHER ADDRESS IN MEMPHIS, TENNESSEE.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15